Neuroprotection of Cerebrolysin in tissue culture models of brain ischemia: Post lesion application indicates a wide therapeutic window

Journal of Neural Transmission

Volumn 113, Issue 7, 2006, Pages 855-868

  Schauer, E ^a   Wronski, R ^a   Patockova, J ^b   Moessler, H ^c   Doppler, E ^c   Hutter Paier, B ^a   Windisch, M ^a  

^a JSW Life Sciences GmbH   (Austria)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Research Initiative Ebewe   (Austria)

Author keywords

Apoptosis; Cerebrolysin; Ischemia; Necrosis; Neurons; Primary cultures

Indexed keywords

CEREBROLYSIN; GLUCOSE; GLUTAMIC ACID; OXYGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN TISSUE; CELL SURVIVAL; CELL VIABILITY; CEREBROVASCULAR DISEASE; CHICKEN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE;

AMINO ACIDS; ANIMALS; APOPTOSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CELLS, CULTURED; CHICK EMBRYO; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; MODELS, BIOLOGICAL; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; TELENCEPHALON; TIME FACTORS;

EID: 33745675491     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0384-3     Document Type: Article

References (83)

1. H Abboud P Amarenco 2004 Thrombolysis and acute stroke MS-Med Sci 20 1104 1108
2. GE Abdelkarim K Gertz C Harms J Katchanov U Dirnagl C Szabó M Endres 2001 Protective effects of PJ34, a novel, potent inhibitor of poly (ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke Int J Mol Med 7 255 260
3. K Abe 2000 Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury J Cerebr Blood F Met 20 1393 1408
4. S Abu-Raya R Tabakman E Blaugrund V Trembovler P Lazarovici 2002 Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells Eur J Pharmacol 434 109 116
5. HP Adams 2001 Treatment of acute ischemic stroke: selecting the right treatment for the right patient Eur Neurol 45 61 66
6. N Ahmed P Näsman NG Wahlgren 2000 Effect of intravenous nimodipine on blood pressure and outcome after acute stroke Stroke 31 1250 1255
7. S Ashwell 2001 Caspases: recent advances in small molecule inhibitors Expert Opin Ther Pat 11 1593 1603
8. T Back 1998 Pathophysiology of the ischemic penumbra - revision of a concept Cell Mol Neurobiol 18 621 638
9. T Back OG Schuler 2004 The natural course of lesion development in brain ischemia Acta Neurochir 89 55 61
10. WF Baker 2005 Thrombolytic therapy: current clinical practice Hematol Oncol Clin N 19 147 181
11. GS Barolin S Koppi E Kapeller 1996 Old and new aspects of stroke treatment with emphasis on metabolically active medication and rehabilitative outcome Euro Rehab 3 135 143
12. S Bastianetto WH Zheng R Quirion 2000 The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C J Neurochem 74 2268 2277
13. A Bethel JR Kirsch RC Koehler SP Finklestein RJ Traystman 1997 Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats Stroke 28 609 616
14. P Calabresi D Centonze LM Cupini C Costa F Pisani G Bernardi 2003 Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies Neurobiol Dis 12 82 88
15. K Chandrasekaran Z Mehrabian B Spinnewyn C Chinopoulos K Drieu G Fiskum 2003 Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761(R)) in global brain ischemia and in excitotoxicity-induced neuronal death Pharmacopsychiatry 36 S89 S94
16. A Chiarugi E Meli M Calvani R Picca R Baronti E Camaioni G Costantino M Marinozzi DE Pellegrini-Giampietro R Pellicciari F Moroni 2003 Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia J Pharmacol Exp Ther 305 943 949
17. E Ciani L Groneng M Voltattorni V Rolseth A Contestabile RE Paulsen 1996 Inhibition of free radical production of free radical scavenging protects from the excitotoxic cell death medicated by glutamate in cultures of cerebellar granule neurons Brain Res 728 1 6
18. D Corbett S Nurse 1998 The problem of assessing effective neuroprotection in experimental cerebral ischemia Prog Neurobiol 54 531 548
19. P Cuevas 1997 Therapeutic prospects for fibroblast growth factor treatment of brain ischemia Neurol Res 19 355 356
20. MA deLeciñana E Díez-Tejedor F Carcller JM Roda 2001 Cerebral ischemia: from animal studies to clinical practice. Should the methods be reviewed? Cerebrovasc Dis 11 20 30
21. G Devuyst J Bogousslavsky 2001 Recent progress in drug treatment for acute ischemic stroke Cerebrovasc Dis 11 71 79
22. J Ekblom H Garpenstrand O Tottmar JA Prince 1998 A cell culture model of cerebral ischemia as a convenient system to screen for neuroprotective drugs J Neural Transm 52 93 98
23. I Ferrer J Ballabriga E Marti E Perez J Alberch E Arenas 1998 BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia Brain Pathol 8 253 261
24. I Ferrer J Krupinski E Goutan E Martí S Ambrosio E Arenas 2001 Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat Acta Neuropathol 101 229 238
25. M Fisher R Ratan 2003 New perspectives on developing acute stroke therapy Ann Neurol 53 10 20
26. GW Glazner F Boland AE Dresse DE Brennemann I Gozes MP Mattson 1999 Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death J Neurochem 73 2341 2347
27. LB Goldstein 2004 Neuroprotective therapy for acute ischaemic stroke: down, but not out Lancet 363 414 415
28. I Gozes DE Brenneman 2000 A new concept in the pharmacology of neuroprotection J Mol Neurosci 14 61 68
29. JC Grotta WS Burgin A El Mitwalli M Long M Campbell LB Morgenstern M Malkoff AV Alexandrov 2001 Intravenous tissue-type plasminogen activator therapy for ischemic stroke - Houston experience 1996 to 2000 Arch Neurol 58 2009 2013
30. A Gschanes V Valouskova M Windisch 1997 Ameliorative influence of a nootropic drug on motor activity of rats after bilateral carotid artery occlusion J Neural Transm 104 1319 1327
31. ZH Guo MP Mattson 2000 Neurotrophic factors protect cortical synaptic terminals against amyloid- and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function Cereb Cortex 10 50 57
32. B Gutmann B Hutter-Paier G Skofitsch M Windisch R Gmeinbauer 2002 In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death Neurotox Res 4 59 65
33. M Hartbauer B Hutter-Paier G Skofitsch M Windisch 2001a Antiapoptotic effects of the peptidergic drug Cerebrolysin on primary cultures of embryonic chick cortical neurons J Neural Transm 108 459 473
34. M Hartbauer B Hutter-Paier M Windisch 2001b Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons J Neural Transm 108 581 592
35. M Holcik H Gibson RG Korneluk 2001 XIAP: apoptotic brake and promising therapeutic target Apoptosis 6 253 261
36. XL Hu IM Johansson T Brännström T Olsson P Wester 2002 Long-lasting neuronal apoptotic cell death in regions with severe ischemia after photothrombotic ring stroke in rats Acta Neuropathol 104 462 470
37. B Hutter-Paier E Grygar M Loibner G Skofitsch M Windisch 2000 Effects of NaCN and ionomycin on neuronal viability and on the abundance of microtubule-associated proteins MAP1, MAP2, and tau in isolated chick cortical neurons Cell Tissue Res 302 39 47
38. B Hutter-Paier E Grygar M Windisch 1996 Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin J Neural Transm 47 267 273
39. B Hutter-Paier E Steiner M Windisch 1998 Cerebrolysin protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia J Neural Transm 53 351 361
40. K Jin XO Mao SP Batteur E [tmp] McEachron A Leahy DA Greenberg 2001 Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor Neuroscience 108 351 358
41. KL Jin XO Mao DA Greenberg 2000 Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia PNAS 97 10242 10247
42. DA Kaku M Goldberg D Choi 1991 Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose Brain Res 554 344 347
43. KK Katsuta H Nakanishi K Shirakawa K Yoshida K Takagi A Tamura 1995 The neuroprotective effect of the novel non competitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats J Cereb Blood Flow Metab 15 345 348
44. 2+ channel antagonists and neuroprotection from cerebral ischemia Eur J Pharmacol 363 1 15
45. J Krieglstein 1997 Excitotoxicity and neuroprotection Eur J Pharm Sci 5 181 187
46. M Kusumoto E Dux KA Hossmann 1997 Effect of trophic factors on delayed neuronal death induced by in vitro ischemia in cultivated hippocampal and cortical neurons Metab Brain Dis 12 113 120
47. G Ladurner 2001 Neuroprotection in acute ischaemic stroke Stroke 32 1
48. G Ladurner P Kalvach H Moessler 2005 Neuroprotective treatment with Cerebrolysin in patients with acute stroke: a randomised controlled trial J Neural Transm 112 415 428
49. W Lee C Bondy 1991 Insulin-like growth factors and cerebral ischemia Ann NY Acad Sci 1993 418 422
50. AS Lesage KL De Loore L Peeters Je Leyesen 1995 Neuroprotective sigma ligands interfere with the glutamate-activated NOS pathway in hippocampal cell culture Synapse 20 156 164
51. DS Liebeskind SE Kasner 2001 Neuroprotection for ischaemic stroke - an unattainable goal? CNS Drugs 15 165 174
52. JG Mielke YT Wang 2005 Insulin exerts neuroprotection by counteracting the decrease in cell-surface GABA(A) receptors following oxygen-glucose deprivation in cultured cortical neurons J Neurochem 92 103 113
53. G Mouw JL Zechel Y Zhou WD Lust WR Selman RA Ratcheson 2002 Caspase-9 inhibition after focal cerebral ischemia improves outcome following reversible focal ischemia Metab Brain Dis 17 143 151
54. M Nakazawa K Matsuno S Mita 1998 Activation of sigma(1) receptor subtype leads to neuroprotection in the rat primary neuronal cultures Neurochem Int 32 337 343
55. B Pettmann J Louis M Sensenbrenner 1979 Morphological and biochemical maturation of neurones cultured in the absence of glial cells Nature 281 378 380
56. Piswanger A, Paier B, Windisch M (1990) Modulation of protein synthesis in a cell-free system from rat brain by Cerebrolysin during development and aging. In: Amino acids: chemistry, biology and medicine. Escom, Leiden, pp 651-657
57. LO Porciúncula JBT Rocha CR Boeck D Vendite DO Souza 2001 Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons Neurosci Lett 299 217 220
58. K Prass U Dirnagl 1998 Glutamate antagonists in therapy of stroke Restor Neurol Neuros 13 3 10
59. T Rootwelt M Dunn M Yudkoff T Itoh R Almaas D Pleasure 1998 Hypoxic cell death in human NT2-N neurons: involvement of NMDA and non-NMDA glutamate receptors J Neurochem 71 1544 1553
60. T Satou T Itoh Y Tamai H Ohde AJ Anderson S Hashimoto 2000 Neurotrophic effects of FPF-1070 (Cerebrolysin) on cultured neurons from chicken embryo dorsal root ganglia, ciliary ganglia, and sympathetic trunks J Neural Transm 107 1253 1262
61. PD Schellinger M Kaste W Hacke 2004 An update on thrombolytic therapy for acute stroke Curr Opin Neurol 17 69 77
62. M Schwab I Antonow-Schlorke U Zwiener R Bauer 1998 Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats J Neural Transm 53 299 311
63. M Schwab R Schaller R Bauer U Zwiener 1997 Morphofunctional effects of moderate forebrain ischemia combined with short-term hypoxia in rats - protective effects of Cerebrolysin Exp Toxicol Pathol 49 29 37
64. VE Shashoua DS Adams A Boyer-Boiteau A Cornell-Bell FH Li M Fisher 2003 Neuroprotective effects of a new synthetic peptide, CMX-9236, in in vitro and in vivo models of cerebral ischemia Brain Res 963 214 223
65. T Shimazaki 2003 Biology and clinical application of neural stem cells Horm Res 60 1 9
66. K Shoge HK Mishima T Saitoh K Ishihara Y Tamura H Shiomi M Sasa 1998 Protective effects of vasoactive intestinal peptide against delayed glutamate neurotoxicity in cultured retina Brain Res 809 127 136
67. E Sigalov M Fridkin DE Brenneman I Gozes 2000 VIP-related protection against iodoacetate toxicity in pheochromocytoma (PC12) cells J Mol Neurosci 15 147 154
68. Y Sugita T Kondo A Kanazawa T Itou Y Mizuno 1993 Protective effect of FPF (Cerebrolysin) on delayed neuronal death in the gerbil - detection of hydroxyl radicals with salicylic acid Brain Nerve 45 325 331
69. AY Sun JH Cheng 1999 Novel targets for therapeutic intervention against ischemic brain injury Clin Neuropharmacol 22 164 171
70. JJ Svoboda 2005 Thrombolysis for acute stroke JAMA 293 421 422
71. Y Tatebayashi MH Lee L LI K Iqbal I Grundke-Iqbal 2003 The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease Acta Neuropathol 105 225 232
72. K Unoki M Lavail 1994 Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor Invest Ophtalmol Vis Sci 35 907 915
73. JJ Vornov RC Tasker JT Coyle 1994 Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia Stroke 25 457 465
74. NG Wahlgren N Ahmed 2004 Neuroprotection in cerebral ischaemia: facts and fancies - the need for new approaches Cerebrovasc Dis 17 153 166
75. PC Waldmeier 2003 Prospects for antiapoptotic drug therapy of neurodegenerative diseases Prog Neuropsychopath 27 303 321
76. JM Wardlaw PAG Sandercock E Berge 2003 Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke - where do we go from here? A cumulative meta-analysis Stroke 34 1437 1442
77. C Wiessner D Sauer D Alaimo PR Allegrini 2000 Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo Cell Mol Biol 46 53 62
78. M Windisch E Albrecht U Eggenreich B Paier 1993 Neurotrophic effects of the nootropic drug Cerebrolysin - a summary Adv Biosci 87 355 356
79. M Windisch A Gschanes B Hutter-Paier 1998 Neurotrophic activities and therapeutic experience with a brain derived peptide preparation J Neural Transm 53 289 298
80. ++-dependent protease, calpain J Neural Transm 107 145 157
81. MBH Youdim O BarAm M Yogev-Falach O Weinreb W Maruyama M Naoi T Amit 2005 Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition J Neurosci Res 79 172 179
82. JH Zhang GG Haddad Y Xia 2000 d-, but not m- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury Brain Res 885 143 153
83. ZG Zhang L Zhang M Yepes Q Jiang QJ Li P Arniego TA Coleman DA Lawrence M Chopp 2002 Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke Circulation 106 740 745